Cerebral dysgeneses secondary to metabolic disorders in fetal life

Handbook of Clinical Neurology

Volumn 87, Issue , 2007, Pages 459-476

  Graf, William D ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTOXIN;

BRAIN CORTEX; BRAIN DISEASE; CONGENITAL MALFORMATION; FEMALE; FETUS; HUMAN; MALE; METABOLIC DISORDER; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE; REVIEW;

BRAIN DISEASES; CEREBRAL CORTEX; FEMALE; FETUS; HUMANS; MALE; METABOLIC DISEASES; NEUROTOXINS; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 67649383891     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)87025-4     Document Type: Review

References (132)

1. Al-Essa M.A., Rashed M.S., Bakheet S.M., et al. Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease. J Perinatol 20 (2000) 120-128
2. Alfano D.P., and Petit T.L. Neonatal lead exposure alters the dendritic development of hippocampal dentate granule cells. Exp Neurol 75 (1982) 275-288
3. Alkondon M., Costa A., Radhakrishnan V., et al. Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett 261 (1990) 124-130
4. Amin-Zaki L., Majeed M.A., Elhassani S.B., et al. Prenatal methylmercury poisoning. Clinical observations over five years. Am J Dis Child 133 (1979) 172-177
5. Aoki S., Okada Y., Nishimura K., et al. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. Radiology 172 (1989) 381-385
6. Ashworth A., Morris S.S., Lira P.I., and Grantham-McGregor S.M. Zinc supplementation, mental development, and behaviour in low birth weight infants in northeast Brazil. Eur J Clin Nutr 52 (1998) 223-227
7. Bamforth F.J., Bamforth J.S., and Applegarth D.A. Structural anomalies in patients with inherited metabolic diseases. J Inherit Metab Dis 17 (1994) 330-332
8. Barkovich A.J., and Peck W.W. MR of Zellweger syndrome. AJNR 18 (1997) 1163-1170
9. Beard J. Iron deficiency alters brain development and functioning. J Nutr 133 5 suppl. 1 (2003) 1468S-1472S
10. Bentley M.E., Caulfield L.E., Ram M., et al. Zinc supplementation affects the activity patterns of rural Guatemalan infants. J Nutr 127 (1997) 1333-1338
11. Bernal J., Guadano-Ferraz A., and Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 13 (2003) 1005-1012
12. Bjugstad K.B., Goodman S.I., and Freed C.R. Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J Pediatr 137 (2000) 681-686
13. Bohm N., Kiesling M., and Lehnert W. Multiple acyl-CoA dehydrogenation deficiency (glutaric acidemia type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr 139 (1982) 60-65
14. Bonnefont J.P., Demaugre F., Prip-Buus C., et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 68 (1999) 424-440
15. Bressler J.P., and Goldstein G.W. Mechanisms of lead neurotoxicity. Biochem Pharmacol 41 (1991) 479-484
16. Brismar J., and Ozand P.T. CT and MR of the brain in the diagnosis of organic acidemias: experiences from 107 patients. Brain Dev 16 suppl. (1994) 104-124
17. Brismar J., and Ozand P.T. CT and MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. AJNR 16 (1995) 675-683
18. Brown L.A., and Baker A. Peroxisome biogenesis and the role of protein import. J Cell Mol Med 7 (2003) 388-400
19. Brown K.H., Peerson J.M., Rivera J.A., and Allen L.H. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials. Am J Clin Nutr 75 (2002) 1062-1071
20. Brun N., Robitaille Y., Grignon A., et al. Pyruvate carboxylase deficiency: prenatal onset of ischemia-like brain lesions in two sibs with the acute neonatal form. Am J Med Genet 84 (1999) 94-101
21. Bull P.C., Thomas G., Rommens J.M., et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5 (1993) 327-337
22. Burd L., and Wilson H. Fetal, infant, and child mortality in a context of alcohol use. Am J Med Genet 127C (2004) 51-58
23. Calaciura F., Mendorla G., Distefano M., et al. Childhood IQ measurements in infants with transient congenital hypothyroidism. Clin Endocrinol (Oxf) 43 (1995) 473-477
24. Caruso P.A., Poussaint T.Y., Tzika A.A., et al. MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome. Neuroradiology 46 (2004) 3-14
25. Castillo-Duran C., Perales C.G., Hertrampf E.D., et al. Effect of zinc supplementation on development and growth of Chilean infants. J Pediatr 138 (2001) 229-235
26. Centers for Disease Control. Centers for Disease Control and Prevention, American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service. Summary of the joint statement on thimerosal in vaccines. MMWR 49 (2000) 622-631
27. Chitayat D., Meagher-Villemure K., Mamer O.A., et al. Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. J Pediatr 121 (1992) 86-89
28. Choi B.H., Lapham L.W., Amin-Zaki L., and Saleem T. Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol 37 (1978) 719-733
29. Cockburn F. Role of infant dietary long-chain polyunsaturated fatty acids, liposoluble vitamins, cholesterol and lecithin on psychomotor development. Acta Paediatr 92 (2003) 19-33
30. Cunniff C., Kratz L.E., Moser A., et al. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 68 (1997) 263-269
31. Czeizel A.E., and Dudas I. Prevention of first occurrence of neural tube defects by periconceptual vitamin supplementation. N Engl J Med 327 (1992) 131-137
32. Davidson P.W., Myers G.J., and Cox C. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA 280 (1998) 701-707
33. De Koning T.J., and Klomp L.W. Serine-deficiency syndromes. Curr Opin Neurol 17 (2004) 197-204
34. De Koning T.J., Jaeken J., Pineda M., et al. Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics 31 (2000) 287-292
35. De Koning T.J., Klomp L.W., van Oppen A.C., et al. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 364 (2004) 2221-2222
36. Delange F. The role of iodine in brain development. Proc Nutr Soc 59 (2000) 75-79
37. Dobyns W.B. Agenesis of the corpus callosum and gyral malformations are frequent manifestations of nonketotic hyperglycinemia. Neurology 39 (1989) 817-820
38. Erdohazi M., Barnes N.D., Robinson M.J., and Lake B.D. Cerebral malformation associated with metabolic disorder. A report of 2 cases. Acta Neuropathol (Berl) 36 (1976) 315-325
39. Evrard P., Caviness Jr. V.S., Prats-Vinas J., and Lyon G. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis. Acta Neuropathol (Berl) 41 (1978) 109-117
40. Faust P.L. Abnormal cerebellar histogenesis in PEX2 Zellweger mice reflects multiple neuronal defects induced by peroxisome deficiency. J Comp Neurol 461 (2003) 394-413
41. Fletcher J.M., Bye A., Naynar V., and Wilcken B. Non-ketotic hyperglycinemia presenting as pachygyria. J Inher Metab Dis 18 (1995) 665-666
42. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol 31 (1989) 145-238
43. Friel J.K., Andrews W.L., Matthew J.D., et al. Zinc supplementation in very-low-birth-weight infants. J Pediatr Gastroenterol Nutr 17 (1993) 97-104
44. Gellera C., Uziel G., Rimoldi M., et al. Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes. Neurology 40 (1990) 495-499
45. Georgieff M.K., Mills M.M., Gordon K., and Wobken J.D. Reduced neonatal liver iron concentrations after uteroplacental insufficiency. J Pediatr 127 (1995) 304-308
46. Goldman L.R., Shannon M.,. and the Committee on Environmental Health of the American Academy of Pediatrics. Technical report: mercury in the environment: implications for pediatricians. Pediatrics 108 (2001) 197-205
47. Gordon N. Nutrition and cognitive function. Brain Dev 19 (1997) 165-170
48. Graf W.D., and Oleinik O.E. The study of neural tube defects after the Human Genome Project and folic acid fortification of foods. Eur J Pediatr Surg 10 suppl. I (2000) 9-12
49. Grandjean P., Weihe P., and White R.F. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19 (1997) 417-428
50. Grantham-McGregor S.M., and Ani C.C. The role of micronutrients in psychomotor and cognitive development. Br Med Bull 55 (1999) 511-527
51. Halas E.S., Eberhardt M.J., Diers M.A., and Sandstead S.S. Learning and memory impairment in adult rats due to severe zinc deficiency during lactation. Physiol Behav 30 (1983) 371-381
52. Hellman J., Vannucci R.C., and Nardis E.E. Blood brain barrier permeability to lactic acid in the newborn dog: lactate as a cerebral metabolic fuel. Pediatr Res 16 (1982) 40-44
53. Hennekam R.C. Congenital brain anomalies in distal cholesterol biosynthesis defects. J Inherit Metab Dis 28 (2005) 385-392
54. Hoffman D.R., Birch E.E., Castaneda Y.S., et al. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr 142 (2003) 669-677
55. Holzbach U., Hanefeld F., Helms G., et al. Localized proton magnetic resonance spectroscopy of cerebral abnormalities in children with carbohydrate-deficient glycoprotein syndrome. Acta Paediatr 84 (1995) 781-786
56. Honein M.A., Moore C.A., and Erickson J.D. Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example. Drug Saf 27 (2004) 1069-1080
57. Horslen S.P., Clayton P.T., Harding B.N., et al. Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. Arch Dis Child 66 (1991) 1027-1032
58. Hug G., Bove K.E., and Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 325 (1991) 1862-1864
59. Inder T., Mocatta T., Darlow B., et al. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 52 (2002) 213-218
60. Jaeken J., Vanderschueren-Lodeweyckx M., Casaer P., et al. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome?. Pediatr Res 14 (1980) 179 (abstract)
61. Jain A., Concato J., and Leventhal J.M. How good is the evidence linking breastfeeding and intelligence?. Pediatrics 109 (2002) 1044-1053
62. Kang S.S., Wong P.W., Bock H.G., et al. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48 (1991) 546-551
63. Kaufmann W.E., Theda C., Naidu S., et al. Neuronal migration abnormality in peroxisomal bifunctional enzyme defect. Ann Neurol 39 (1996) 268-271
64. Kelley R.L., Roessler E., Hennekam R.C., et al. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?. Am J Med Genet 66 (1996) 478-484
65. Kerrigan J.F., Aleck K.A., Tarby T.J., et al. Fumaric aciduria: clinical and imaging features. Ann Neurol 47 (2000) 583-588
66. Kimura S., Hara M., Nezu A., et al. Two cases of glutaric aciduria type 1: clinical and neuropathological findings. J Neurol Sci 123 (1994) 38-43
67. Koren G., Pastuszak A., and Ito S. Drugs in pregnancy. N Engl J Med 338 (1998) 1128-1137
68. Korman S.H., Boneh A., Ichinohe A., et al. Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation. Ann Neurol 56 (2004) 139-143
69. Kriegstein A.R. Cortical neurogenesis and its disorders. Curr Opin Neurol 9 (1996) 113-117
70. 13C-glycine breath test. Ann Neurol 59 (2006) 862-867
71. Levy H.L., Lobbregt D., Sansaricq C., and Snyderman S.E. Comparison of phenylketonuric and nonphenylketonuric sibs from untreated pregnancies in a mother with phenylketonuria. Am J Med Genet 44 (1992) 439-442
72. Levy H.L., Lobbregt D., Barnes P.D., and Poussaint T.Y. Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring. J Pediatr 128 (1996) 770-775
73. Li Q., Guo-Ross S., Lewis D.V., et al. Dietary prenatal choline supplementation alters postnatal hippocampal structure and function. J Neurophysiol 91 (2004) 1545-1555
74. Liu P.C., McAndrew P.E., and Kaler S.G. Rapid and robust screening of the Menkes disease/occipital horn syndrome gene. Genet Test 6 (2002) 255-260
75. Liu J., Raine A., Venables P.H., et al. Malnutrition at age 3 years and lower cognitive ability at age 11 years: independence from psychosocial adversity. Arch Pediatr Adolesc Med 157 (2003) 593-600
76. Loosen P.T. Effects of thyroid hormones on central nervous system in aging. Psychoneuroendocrinology 17 (1992) 355-374
77. Martinez-Lage J.F., Casas C., Fernandez M.A., et al. Macrocephaly, dystonia, and bilateral temporal arachnoid cysts: glutaric aciduria type 1. Childs Nerv Syst 10 (1994) 198-203
78. Mauceri L., Ruggieri M., Pavone V., et al. Craniofacial anomalies, severe cerebellar hypoplasia, psychomotor and growth delay in a child with congenital hypothyroidism. Clin Dysmorphol 6 (1997) 375-378
79. Menkes J.H. Disorders of copper metabolism. In: Rosenberg R., Prusiner S., DiMauro S., and Barchi R. (Eds). The Molecular and Genetic Basis of Neurologic Disease (1997), Butterworth-Heinemann, Boston 1273-1290
80. Michotte A., De Meirleir L., Lissens W., et al. Neuropathological findings of a patient with pyruvate dehydrogenase E1 alpha deficiency presenting as a cerebral lactic acidosis. Acta Neuropathol (Berl) 85 (1993) 674-678
81. Morgane P.J., Austin-LaFrance R., et al. Prenatal malnutrition and development of the brain. Neurosci Biobehav Rev 17 (1993) 91-128
82. Morgane P.J., Mokier D.J., and Galler J.R. Effects of prenatal protein malnutrition on the hippocampal formation. Neurosci Biobehav Rev 26 (2002) 471-483
83. MRC Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338 (1991) 131-137
84. National Research Council. Toxicology Effects of Methylmercury (2000), National Academy Press, Washington, DC
85. Neugebauer R., Hoek H.W., and Susser E. Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood. JAMA 282 (1999) 455-462
86. North K.N., Hoppel C.L., De Girolami U., et al. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 127 (1995) 414-420
87. Oberdoerster J., Guizzetti M., and Costa L.G. Effect of phenylalanine and its metabolites on the proliferation and viability of neuronal and astroglial cells: possible relevance in maternal phenylketonuria. J Pharmacol Exp Ther 295 (2000) 295-301
88. Okeda R., Gei S., Chen I., et al. Menkes' kinky hair disease: morphological and immunohistochemical comparison of two autopsied patients. Acta Neuropathol (Berl) 81 (1991) 450-457
89. Ortiz E., Pasquini J.M., Thompson K., et al. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77 (2004) 681-689
90. Peters V., Penzien J.M., Reiter G., et al. Congenital disorder of glycosylation IId (CDG-IId) - a new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics 33 (2002) 27-32
91. Petry C.D., Eaton M.A., Wobken J.D., et al. Iron deficiency of liver, heart, and brain in newborn infants of diabetic mothers. J Pediatr 121 (1992) 109-114
92. Pfeiffer C.C., and Braverman E.R. Zinc, the brain and behavior. Biol Psychiatry 17 (1982) 513-532
93. Pierre K., and Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94 (2005) 1-14
94. Powers J.M. Demyelination in peroxisomal diseases. J Neurol Sci 228 (2005) 206-207
95. Press G.A., Barshop B.A., Haas R.H., et al. Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. Am J Neuroradiol 10 (1989) 315-321
96. Ramaekers V.T., and Blau N. Cerebral folate deficiency. Devel Med Child Neurol 46 (2004) 843-851
97. Ramos H.E., and Weiss R.E. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone. Thyroid 16 (2006) 211-216
98. Rey J. Breastfeeding and cognitive development. Acta Paediatr 92 suppl. 442 (2003) 11-18
99. Roux C., Wolf C., Mulliez N., et al. Role of cholesterol in embryonic development. Am J Clin Nutr 71 5 suppl. (2000) 1270S-1279S
100. Rovet J.F. Congenital hypothyroidism: long-term outcome. Thyroid 9 (1999) 741-748
101. Sankar R., Pulger T., Rai B., et al. Epidemiology of endemic cretinism in Sikkim, India. Indian J Pediatr 65 (1998) 303-309
102. Sarnat H.B., Trevenen C.L., and Darwish H.Z. Ependymal abnormalities in cerebro-hepato-renal disease of Zellweger. Brain Dev 15 (1993) 270-277
103. Sasaki M., Kimura M., Sugai K., et al. 3-Hydroxyisobutyric aciduria in two brothers. Pediatr Neurol 18 (1998) 253-255
104. Sazawal S., Bentley M., Black R., et al. Effect of zinc supplementation on observed activity in low socioeconomic Indian preschool children. Pediatrics 98 (1996) 1132-1137
105. Scrimshaw N.S. Iron deficiency. Sci Am 265 (1991) 46-52
106. Shevell M.I., Matthews P.M., Scriver C.R., et al. Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 11 (1994) 224-229
107. Shevell M.I., Didomenicantonio G., Sylvain M., et al. Glutaric acidemia type II: neuroimaging and spectroscopy evidence for developmental encephalomyopathy. Pediatr Neurol 12 (1995) 350-353
108. Siddappa A.M., Georgieff M.K., Wewerka S., et al. Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res 55 (2004) 1034-1041
109. Spohr H.L., Willms J., and Steinhausen H.C. The fetal alcohol syndrome in adolescence. Acta Paediatr Suppl 404 (1994) 19-26
110. St Clair D., Xu M., Wang P., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294 (2005) 557-562
111. Stibler H., Westerberg B., Hanefeld F., and Hagberg B. Carbohydrate-deficient glycoprotein (CDG) syndrome - a new variant, type III. Neuropediatrics 24 (1993) 51-52
112. Streissguth A.P., and O'Malley K. Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin Clin Neuropsychiatry 5 (2000) 177-190
113. Streissguth A.P., Landesman-Dwyer S., Martin J.C., and Smith D.W. Teratogenic effects of alcohol in humans and laboratory animals. Science 209 (1980) 353-361
114. Stromland K., Nordin V., Miller M., et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36 (1994) 351-356
115. Takanashi J., Fujii K., Sugita K., and Kohno Y. Neuroradiologic findings in glutaric aciduria type II. Pediatr Neurol 20 (1999) 142-145
116. Tint G.S., Irons M., Elias E.R., et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330 (1994) 107-113
117. Trottier G., Srivastava L., and Walker C.D. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci 24 (1999) 103-115
118. Uziel G., Garavaglia B., Ciceri E., et al. Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy. Pediatr Neurol 13 (1995) 333-335
119. Vakhrushev S.Y., Mormann M., and Peter-Katalinic J. Identification of glycoconjugates in the urine of a patient with congenital disorder of glycosylation by high-resolution mass spectrometry. Proteomics 6 (2006) 983-992
120. Van der Knaap M.S., and Valk J. The MR spectrum of peroxisomal disorders. Neuroradiology 33 (1991) 30-37
121. Van der Knaap M.S., Jakobs C., Hoffmann G.F., et al. D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity?. Ann Neurol 45 (1999) 111-119
122. Van der Put N.M.J., Steegers-Theunissen R.P.M., Frosst P., et al. Mutated methylene-tetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346 (1995) 1070-1071
123. Vannucci R.C., and Vannucci S.J. Glucose metabolism in the developing brain. Semin Perinatol 24 (2000) 107-115
124. Volpe J.J. Neurology of the Newborn. 4th edn. (2001), WB Saunders, Philadelphia
125. Walker V., Mills G.A., Hall M.A., et al. A fourth case of fumarase deficiency. J Inherit Metab Dis 12 (1989) 331-332
126. Wang X., Jakobs C., and Bawle E.V. d-2-Hydroxyglutaric aciduria with absence of corpus callosum and neonatal intracranial haemorrhage. J Inherit Metab Dis 26 (2003) 92-94
127. Wauben I.P., and Wainwright P.E. The influence of neonatal nutrition on behavioral development: a critical appraisal. Nutr Rev 57 (1999) 35-44
128. 2+: a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 21 (2000) 395-401
129. Wilcken B., Leung K.C., Hammond J., et al. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 341 (1993) 407-408
130. Yang Z., Yamada J., Zhao Y., et al. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 288 (2002) 2163-2166
131. Yoshimura N., and Kudo H. Mitochondrial abnormalities in Menkes' kinky hair disease (MKHD). Electron-microscopic study of the brain from an autopsy case. Acta Neuropathol (Berl) 59 (1983) 295-303
132. Zeisel S.H. Choline: an essential nutrient for humans. Nutrition 16 (2000) 669-671